Mammoth emerges to bring CRISPR into diagnostic space

Mammoth Biosciences (San Francisco, Calif.) debuted on April 26 with a CRISPR-based diagnostic platform and an exclusive license to IP covering work from CRISPR pioneer Jennifer Doudna.

Read the full 272 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE